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C
hronic, culture-negative septic arthritis represents a
major clinical dilemma. It often results in prolonged
courses of antimicrobial therapy, whichmay or may not
have activity against the organism responsible for the infection.
It is not possible to cultivate all types of pathogens in vitro with
use of traditional laboratory testing methods, but emerging
techniques can be helpful to define the etiology of these in-
fections in some cases. We describe a case of a periprosthetic
joint infection in a thirty-year-old woman with juvenile rheu-
matoid arthritis (JRA) and hypogammaglobulinemia, who
developed septic arthritis after prolonged pneumonia. She re-
ceived multiple courses of antimicrobial therapy without im-
provement of the joint symptoms. The microbiologic diagnosis
was made with use of 16S ribosomal RNA (rRNA) gene am-
plification and sequencing from synovial fluid and tissue. The
patient gave permission for this information to be submitted
for publication.
Case Report
Athirty-year-old woman with JRA and hypogammaglobu-linemia was referred for evaluation of an infection at the
site of a total knee arthroplasty. Her JRA had been managed
with multiple courses of corticosteroids, infliximab, and, more
recently, rituximab. She had undergone bilateral shoulder and
knee synovectomy, and right elbow synovectomy, and finally
had required left total knee arthroplasty in 2006.
In the fall of 2009, the patient was hospitalized because of
pneumonia, which had a prolonged course, with several hos-
pitalizations due to recurrences over two months. Chest radio-
graphs confirmed right upper lobe pneumonia, which later
progressed to bilateral pneumonia. She was treated with azith-
romycin and ceftriaxone and initially showed improvement,
but she then had a relapse with recurrent symptoms. During
the multiple relapses, she was treated with vancomycin and
cefepime followed by ertapenem. She had five bronchoscopy
procedures. The bronchoscopies all showed purulent secretions,
but all cultures were negative, including fungal andmycobacterial
cultures. Polymerase chain reaction (PCR) for Mycoplasma
pneumoniae from a nasopharyngeal swab was also negative.
Her condition improved in October 2009, and the course of
antibiotics was discontinued.
In November 2009, the patient developed redness, pain,
and swelling at the site of the prosthetic left knee. Arthro-
centesis revealed 50,500 nucleated white blood cells in the
synovial fluid, 79% of which were neutrophils. She underwent
irrigation and drainage with synovectomy of the knee, but the
prosthesis was retained. Copious amounts of yellow turbid
fluid were found intraoperatively, but all cultures were neg-
ative. The patient received six weeks of empiric antibiotic
treatment with intravenous (IV) vancomycin and oral cip-
rofloxacin and had clinical improvement. She was then
started on chronic suppressive therapy with oral trimethoprim-
sulfamethoxazole.
At a clinic visit several weeks later, she was noted to have
persistent knee redness and swelling while she was still taking
trimethoprim-sulfamethoxazole. She was then admitted for
evaluation of presumed recurrent periprosthetic joint infec-
tion. Arthrocentesis at this time revealed 48,000 nucleated
white blood cells in the synovial fluid, 89% of which were
neutrophils. In January 2010, the patient had repeat surgical
drainage and irrigation with removal of the total knee implant
as well as spacer placement. During this procedure, two batches
of cement were used for the spacer block and a third batch of
cement was used for the intramedullary dowels, with 2 g
of vancomycin and 2.4 g of tobramycin used in each batch of
cement. All intraoperative cultures were negative. Empiric
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antibiotic treatment, with daptomycin, ciprofloxacin, and met-
ronidazole, was resumed.
In December 2009, the patient had had a low immuno-
globulin G (IgG) level, low IgA level, and suppression of all IgG
subclasses, along with a very poor response to a test dose of
pneumococcal vaccine. These changes were thought to be due
to her prior treatment with rituximab. IV immunoglobulin
infusions were started during the January 2010 hospitalization.
Because of the recurrent knee joint infection and negative
cultures, samples of synovial tissue and fluid were sent for 16S
rRNA gene amplification, and sequencing was obtained for the
samples of synovial tissue and fluid. Both samples were strongly
positive for M. pneumoniae. An organism-specific PCR for
M. pneumoniae (targeting the P1 gene) was performed on the
knee tissue and was also positive. Bronchoalveolar lavage fluid
obtained during her hospitalization with pneumonia in Sep-
tember 2009 was retrospectively assayed by PCR and was found
to be strongly positive for M. pneumoniae.
Daily oral azithromycin (500 mg) was added to the an-
tibiotic regimen. The knee symptoms improved substantially
two weeks after the azithromycin was started. She completed
six weeks of azithromycin therapy and was then monitored
while she was off all antibiotics for twelve weeks; there was no
recurrence of symptoms. She had implantation of a new total
knee prosthesis in July 2010, six months after the joint ex-
plantation. M. pneumoniae PCR of synovial fluid and deep
tissue obtained after the reimplantation was weakly positive.
She was again treated with IV vancomycin and ertapenem for
six weeks and oral azithromycin for twomonths postoperatively.
All antibiotic therapy was then stopped. IV immunoglobulin
infusions were continued by the patient’s immunologist. At a
six-month follow-up evaluation, after she had been off anti-
biotics for four months, her condition was stable and she had
had no recurrent symptoms.
Discussion
Wereport a case of periprosthetic joint infection caused byM. pneumoniae diagnosed with 16S rRNA gene ampli-
fication and sequencing in a patient with hypogammaglobu-
linemia. The hypogammaglobulinemia was most likely due to
treatment for JRA. There are a few reports of periprosthetic
joint infection caused byMycoplasma hominis1, but, to the best
of our knowledge, this is the first report of periprosthetic joint
infection attributable to M. pneumoniae.
Mycoplasmas are the smallest self-replicating organisms
that are capable of cell-free existence. Mycoplasmas are mu-
cosal pathogens, usually in the respiratory or urogenital tract.
Native joint infections from mycoplasma species are rare. Other
than M. pneumoniae2-5, mycoplasma species isolated from areas
of septic arthritis of native joints include M. hominis5, Myco-
plasma genitalium2, Mycoplasma salivarium5,6, and Ureaplasma
urealyticum5. M. hominis has also been found in patients with
prosthetic joints1.
Arthritis of native joints due to mycoplasma species has
been described primarily in adults with hypogammaglobulin-
emia3,7 and in children with or without hypogammaglobulin-
emia3,4. In these individuals, the immune system responds poorly
and cannot eliminate mycoplasma infection. Subsequently, ex-
trapulmonary complications can result, with or without pre-
ceding pneumonia.
The authors of one study of eighteen patients with pri-
mary antibody deficiency and severe, chronic, culture-negative
arthritis found, by culturing synovial fluid and biopsy material
for mycoplasma, that mycoplasmal infection was the most
commonly identified cause5. Most patients presented with a
monoarthritis, usually involving a large joint such as the knee,
shoulder, elbow, or hip. The joint fluid was usually yellow and
turbid or purulent. If diagnosis and adequate treatment had
been delayed, widespread disease often developed that involved
multiple joints. None of the patients were systemically ill at
presentation, in contrast to the usual clinical picture in acute
bacterial septic arthritis5. In our literature search, we found
only one published report of M. pneumoniae causing native
knee and wrist joint infection in an adult with normal levels of
immunoglobulins; this joint infection was identified two weeks
after an atypical pneumonia8.
The diagnosis of mycoplasma infection is challenging.
Mycoplasma species lack a cell wall and are not detectable by
Gram staining. Routine laboratory methods used in the culture
of joint fluid do not support the growth of mycoplasma species.
Unfortunately, there are no widely available diagnostic tests
that allow reliable, rapid diagnosis of M. pneumoniae directly
from synovial fluid. Thus, a high clinical suspicion is essential
for early treatment of mycoplasma infections; however, the
diagnosis is often made in retrospect.
Serology continues to be the mainstay of laboratory di-
agnosis ofM. pneumoniae infection, with a fourfold increase in
titer on enzyme immunoassay of paired acute and convalescent
sera or a single high anti-mycoplasma complement fixation
antibody titer of >1:128 indicating the presence of the infec-
tion9. IgM antibodies typically appear early in most microbial
infections and have a short half-life. However, reinfection with
M. pneumoniae is common, and IgM response in reinfections
is either minimal or undetectable10. When available, PCR per-
formed on respiratory samples, which can be done rapidly and
has a high specificity, may be helpful, especially when com-
bined with serology. The sensitivity of PCR decreases as the
duration of symptoms and the time to sample collection in-
crease, with a peak sensitivity of 48% at days 0 to 2111. Our
patient initially had a negative M. pneumoniae PCR from a
nasopharyngeal swab, but subsequent PCR of the bronchoal-
veolar lavage collected days later was positive. The negative
PCR could have been due to the variability of the collection
technique or could have reflected a relative difference in or-
ganism titers on the days these samples had been collected.
16S rRNA gene amplification and sequencing can be
useful for bacterial identification and for discovery of novel
bacteria. The 16S gene is present in almost all bacteria, and 16S
rRNA gene sequencing is particularly useful in expediting the
identification of slow-growing bacteria, which may take many
weeks to grow in culture or to exhibit relevant biochemical
reactions for identification purposes12; in identification of a
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novel bacterial genus and species13; and, most importantly, in
detection of bacteria that cannot be grown on culture, such as
mycoplasma species13. Currently, 16S rRNA gene amplification
performed directly on clinical specimens is not widely available
in most hospital settings. It is performed on a research basis in
some centers and is performed by some reference laboratories,
although the acceptable sample types for analysis vary by
laboratory.
To the best of our knowledge, ours is the first case report
ofM. pneumoniae periprosthetic joint infection. A diagnosis of
mycoplasma infection should be considered in patients with
hypogammaglobulinemia and culture-negative septic arthritis
who do not respond to traditional antibiotics, especially if
patients have recently had upper respiratory symptoms. Pa-
tients with delayed diagnosis may sustain considerable joint
damage. Treatment for mycoplasmal arthritis is usually azith-
romycin3 or tetracycline5; prolonged treatment may be required
(three months to two years)5,14. Intramuscular immuno-
globulin or IV immunoglobulin can be considered for severe
infection5. n
Zhuolin Han, MD, MS
Carey-Ann D. Burnham, PhD
John Clohisy, MD
Hilary Babcock, MD, MPH
Department of Medicine (Z.H. and H.B.), Pediatrics (C.-A.D.B.),
Pathology & Immunology (C.-A.D.B.), and Orthopedics (J.C.),
Washington University School of Medicine, 660 South Euclid Avenue,
Campus Box 8116, St. Louis, MO 63110.
E-mail address for Z. Han: zhan@dom.wustl.edu.
E-mail address for C.-A.D. Burnham: Burnham_c@kids.wustl.edu.
E-mail address for J. Clohisy: clohisyj@wudosis.wustl.edu.
E-mail address for H. Babcock: hbabcock@im.wustl.edu
References
1. Sneller M, Wellborne F, Barile MF, Plotz P. Prosthetic joint infection with Myco-
plasma hominis. J Infect Dis. 1986;153:174-5.
2. Tully JG, Rose DL, Baseman JB, Dallo SF, Lazzell AL, Davis CP. Mycoplasma
pneumoniae and Mycoplasma genitalium mixture in synovial fluid isolate. J Clin
Microbiol. 1995;33:1851-5.
3. Azumagawa K, Kambara Y, Murata T, Tamai H. Four cases of arthritis associated
with Mycoplasma pneumoniae infection. Pediatr Int. 2008;50:511-3.
4. Schwartz R, Garty BZ. Variability of arthritis associated with mycoplasma
pneumoniae infection in children. Clin Pediatr (Phila). 2005;44:633-6.
5. Franz A, Webster AD, Furr PM, Taylor-Robinson D. Mycoplasmal arthritis in pa-
tients with primary immunoglobulin deficiency: clinical features and outcome in 18
patients. Br J Rheumatol. 1997;36:661-8.
6. So AK, Furr PM, Taylor-Robinson D, Webster AD. Arthritis caused by Mycoplasma
salivarium in hypogammaglobulinaemia. Br Med J (Clin Res Ed). 1983;286:762-3.
7. Sordet C, Cantagrel A, Schaeverbeke T, Sibilia J. Bone and joint disease asso-
ciated with primary immune deficiencies. Joint Bone Spine. 2005;72:503-14.
8. Davis CP, Cochran S, Lisse J, Buck G, DiNuzzo AR, Weber T, Reinarz JA. Isolation
of Mycoplasma pneumoniae from synovial fluid samples in a patient with pneumonia
and polyarthritis. Arch Intern Med. 1988;148:969-70.
9. Sa´nchez-Vargas FM, Go´mez-Duarte OG. Mycoplasma pneumoniae-an emerging
extra-pulmonary pathogen. Clin Microbiol Infect. 2008;14:105-17.
10. Sillis M. The limitations of IgM assays in the serological diagnosis of Myco-
plasma pneumoniae infections. J Med Microbiol. 1990;33:253-8.
11. Thurman KA, Walter ND, Schwartz SB, Mitchell SL, Dillon MT, Baughman AL,
Deutscher M, Fulton JP, Tongren JE, Hicks LA, Winchell JM. Comparison of laboratory
diagnostic procedures for detection of Mycoplasma pneumoniae in community
outbreaks. Clin Infect Dis. 2009;48:1244-9.
12. Heller R, Jaulhac B, Charles P, De Briel D, Vincent V, Bohner C, Pie´mont Y,
Monteil H. Identification of Mycobacterium shimoidei in a tuberculosis-like cavity
by 16S ribosomal DNA direct sequencing. Eur J Clin Microbiol Infect Dis. 1996;15:
172-5.
13. Woo PC, Lau SK, Teng JL, Tse H, Yuen KY. Then and now: use of 16S rDNA gene
sequencing for bacterial identification and discovery of novel bacteria in clinical
microbiology laboratories. Clin Microbiol Infect. 2008;14:908-34.
14. O’Sullivan MV, Isbel NM, Johnson DW, Rencken K, Byrne S, Graham MM,
Playford EG. Disseminated pyogenic Mycoplasma pneumoniae infection in a renal
transplant recipient, detected by broad-range polymerase chain reaction. Clin Infect
Dis. 2004;39:e98-9.
e103(3)
THE JOURNAL OF BONE & JOINT SURGERY d J B J S .ORG
VOLUME 93-A d NUMBER 18 d SEPTEMBER 21, 2011
M. PNEUMONIAE PERIPROSTHET IC JO INT INFECT ION IDENT IF I ED
BY GENE AMPL IF ICAT ION AND SEQUENCING
